Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page
- Check5 days agoChange DetectedRevision badge updated from v3.6.0 to v3.6.2, indicating a recent release of the page's underlying platform or content. This does not change the study details displayed on the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays a recruitment status indicating no longer looking for participants and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) plus a Revision: v3.6.0, with a minor heading formatting change to Intervention/Treatment.SummaryDifference0.4%

- Check27 days agoChange DetectedThe page shows revision v3.5.5, replacing v3.5.4, indicating a new version of the page has been published.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page's related topics/MeSH terms section has been updated to remove Melanoma, related topics:, and MedlinePlus Genetics; this changes how the study is indexed for topic-based searches without altering the study details themselves.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry was added: v3.5.4, replacing the previous v3.5.3. This represents a minor update to the page's revision metadata without altering shown trial content or functionality.SummaryDifference0.0%

- Check55 days agoChange DetectedMelanoma was added as an additional relevant MeSH term and MedlinePlus Genetics was added as a related topic, improving indexing and discoverability of the study.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.